Carlito, Ephraim D.
HRN: 16-82-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
01/04/2023
01/11/2023
ORAL
3ml
Q12h
Urti
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes